Fakultní nemocnice v Motole Fakultní nemocnice v Motole

přejdi na obsah | přejdi na menu | přejdi na vyhledávání

Publikace 2012

 Zahraniční publikace s impact factorem:

  • Vesely S, Jarolim L, Schmidt M, Minarik I, Dusek P, Babjuk M. Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome.  World J Urol. 2012 Jun 10. IF 2.411
  • Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W: European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract]. Actas Urol Esp. 2012 Jan;36(1):2-14. Epub 2011 Oct 29. Spanish. IF 0,455
  • Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, et al.: Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery. Eur Urol. 2012 Oct;62(4):677-684. IF 8,493
  • Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Rouprêt M.EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]. Actas Urol Esp. 2012 Jul-Aug;36(7):389-402. IF 0,455
  • Soukup V, Babjuk M, Bellmunt J, Dalbagni G, Giannarini G, Hakenberg OW, Herr H, Lechevallier E, Ribal MJ.Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. Eur Urol. 2012 Aug;62(2):290-302. IF 8,493
  • Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF.Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int. 2012 Jun 21. doi: 10.1111/j.1464-410X.2012.11322.x. IF 2,844
  • Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS,et al.Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy. Eur Urol. 2012 Jun 16. [Epub ahead of print]. IF 8,493
  • Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, et al.Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy. Eur Urol. 2012 Jun 22. [Epub ahead of print]. IF 8,493
  • Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS et al. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int. 2012 Jul 19. doi: 10.1111/j.1464-410X.2012.11356.x. [Epub ahead of print]. IF 2,844
  • Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS.Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Jul 26. [Epub ahead of print]. IF 2.411
  • Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A et al.: Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder Cancer. Eur Urol. 2012 Aug 21. [Epub ahead of print]. IF 8,493
  • Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A et al.: Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU Int. 2012 Sep 3. doi: 10.1111/j.1464-410X.2012.11433.x. [Epub ahead of print]. IF 2,844
  • Rink M, Xylinas E, Babjuk M, Pycha A et al.: Smoking Reduces the Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Non-muscle-invasive Bladder Cancer. Eur Urol. 2012 Sep 5. pii: S0302-2838(12)01010-X. doi: 10.1016/j.eururo.2012.08.057. [Epub ahead of print]. IF 8,493
  • Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M et al.: ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol. 2012 Sep 5. pii: S0302-2838(12)01014-7. doi: 10.1016/j.eururo.2012.08.061. [Epub ahead of print]. IF 8,493
  • Schmidt M, Rejchrt M, Binek B, Jarolím L. Percutaneous afferent neurostimulation of nervus ischiadicus branches with neuroresonance frequency – Pilot project. Eur Urol Suppl 2012; 11(4):100. IF 1,827
  • Chocholatý M, Lisý L, Havlová K, Schmidt M, Stolz J, Babjuk M. The significance of ADC value in different types of renal tumors Eur Urol Suppl 2012; 11(4):114. IF 1,827
  • Chocholatý M, Diblik J, Kříž J. Penile vibratory stimulation in patients with spinal cord Injury Eur Urol Suppl 2012; 11(4):86. IF 1,827
  • Tachezy R, Hrbacek J,  Heracek J. Salakova M, Smahelova J, Ludvikova V, Svec A, Urban M, Hamsikova E. HPV persistence and its oncogenic role in prostate tumors. J Med Virol 2012;84:1636-1645. IF 2,820
  • Gakis G, Ali-El-Dein B, Babjuk M, Thalmann G, Hrbáček J, Macek P, Shaaban AA, Stenzl A. A multiinstitutional study on risk factors of urethral recurrences in female patients with ileal neobladder. Eur Urol Suppl 2012;11:e608. IF 1,827
  • Hrbáček J, Pazourková E, Brisuda A, Soukup V, Mareš J, Čapoun O,  Korabečná M, Hořínek A, Hanuš T, Babjuk M: Second voided urine samples give better yields of cell-free DNA than first morning urine in bladder cancer patients and controls. Eur Urol Suppl 2012;11(4):89. IF 1,827
  • Schmidt M, Hanek P, Dušek P, Jarolím L, Babjuk M: Laparoscopic retroperitoneal lymf node dissection in testicular cancer treatment. Eur Urol Suppl 2012; 11(4):84. IF 1,827
  • Jarolím L, Schmidt M, Chocholatý M, Minárik I, Rejchrt M, Jerie J, Veselý Š, Babjuk M, Bartoníčková K, Havlová K.: Sex reassignment Sumery in male to femal transsexualism – 20 years experience. Eur Urol Suppl 2012; 11(4):85. IF 1,827
  • Jarolim L., Schmidt M., Chocholaty M., Minarik I., Rejchrt M., Jerie J., Vesely S, Babjuk M., Bartonickova K., Havlova K.: Refinement of Male-to-Female Sex Reassignment Surgery during 20 years - Experience with 200 Cases. Urology 80, (Supplement 3A) 2012, S16-17. ISSN 0090-4295 IF 2,428
  • Veselý Š, Jarolím L, Schmidt M, Dušek P, Babjuk M: Time to PSA nadir is related to the risk of biochemical recurrence after radiál prostatectomy. Eur Urol Suppl 2012; 11(4):125. IF 1,827
  • Babjuk M, Macek P, Hrbacek J, Soukup V, Brisuda A, Jarolim L, Hanus T: Urethra Sparing Cystectomy and Orthotopic Diversion in Females: Oncological Outcomes, Risk and Treatment of Urethral Recurrence. Urology 80, (Supplement 3A) 2012, S148. ISSN 0090-4295 IF 2.428
  • Brisuda A., Hrbacek J., Babjuk M., Jarolim L.: Role of second transurethral resection in non-muscle invasive urothelial bladder cancer. Eur Urol Suppl. 11,4,2012, 103. ISSN 1569-9056. IF 1,827
  • Kotaska K, Dusek P, Prusa R, Vesely S, Babjuk M. Urine and Serum Cathepsin B Concentrations in the Transitional Cell Carcinoma of the Bladder.Journal of Clinical Laboratory Analysis 26: 61–65 (2012). IF 1,384
  • Han SS, Yeager M, Moore LE, Wei MH, Pfeiffer R, Toure O, Purdue MP, Johansson M, Scelo G, Chung CC, Gaborieau V, Zaridze D, Schwartz K, Szeszenia-Dabrowska N, Davis F, Bencko V, Colt JS, Janout V, Matveev V, Foretova L, Mates D, Navratilova M, Boffetta P, Berg CD, Grubb RL 3rd, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Albanes D, Weinstein SJ, Virtamo J, Burdett L, Brisuda A, McKay JD, Fraumeni JF Jr, Chatterjee N, Rosenberg PS, Rothman N, Brennan P, Chow WH, Tucker MA, Chanock SJ, Toro JR.: The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet. 2012 Mar 1;21(5):1190-200. IF 7,636

 

Publikace v českých recenzovaných časopisech:

  • Rejchrt M Využití neuromodulace v léčbě dysfunkcí dolních močových cest. Ces Urol 2012;16(1): 5 -12. ISSN 1211-8729
  • Křepelová A, Puchmajerová A, Vasovčák P, Chocholatý M. Syndrom BHD. Klinická onkologie Suppl. 2012;25:18-20. ISSN pro online přístup: 1802-5307, ISSN 0862-495X
  • Pádr R, Polovinčák M, Roček M, Chocholatý M, Hanek P. Endovaskulární léčba erektilní dysfunkce. Česká radiologie 2012;66(2):250. ISSN: 1210-7883
  • Lisý J, Chocholatý M, Havlová K, Campr. V. Význam ADC hodnoty pro diferenciaci nádorů ledvin. Ces Radiol 2012;66(3): 317 -336.ISSN: 1210-7883
  • Buchler T, Dusek P, Brisuda A, Simonova K, Fencl P, Jarkovsky J, Babjuk M, Abrahamova J.Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors. Klin Onkol. 2012;25(3):178-83. ISSN 1802-5307
  • Schmidt M, Mareš J, Jarolím L, Černý M, Veselý Š, Babjuk M Stanovení exprese SHB v tkáni karcinomu prostaty: Využití v diagnostice a prognostice. Ces Urol 2012; 16(1): 58–66. ISSN 1211-8729
  • Jarolím L.: Editorial. Česká urologie 2012,16,1,3. ISSN 1211-8729
  • Jarolím L, Veselý Š, Babjuk M, Schmidt M, Dušek P, Malinová B, Prausová J: Časná salvage radioterapie po radikální prostatektomii indikovaná u pacientů s rostoucí hladinou PSA v hodnotách nižších, než je konvenční hranice biochemické recidivy 0,2 ng/ml. Česká urologie 2012,16,2,92-100. ISSN 1211-8729
  • Jarolim L., Jerie J., Bartonickova K, Rejchrt M.,Schmidt M., Havlova K., Čechová M., Minarik I., Babjuk M.: Chirurgická konverze u transsexualismu. Dermatologie pro praxi 2012,6,(4), 72-75. ISSN - 1802-2960
  • Brisuda A: EUROPEAN UROLOGICAL SCHOLARSHIP PROGRAMME (EUSP): REÁLNÁ MOŽNOST PRO ČESKÉHO UROLOGA? Ces Urol 2012;16(2): 135 -136

 

Kapitoly v zahraničních monografiích:

  • Brisuda A, Hrbáček J, Babjuk M: Treatment of Low-risk Non-muscle-invasive Bladder Cancer. European Urological Review, Summer 2012

 

 

Partneři

© Fakultní nemocnice v Motole 2012. Všechna práva vyhrazena.

Odebírejte novinky (RSS)

Mapa webu

developed by MEDIA FACTORY